Cayenne Medical commenced U.S. launch of the BioWick™ SureLock™ Implant, an interpositional scaffold wick designed to address the biology issue associated with rotator cuff repair failure.
The BioWick scaffold wick comprises aligned, copolymer microfibers designed to mimic the extracellular matrix of a rotator cuff tendon. SureLock is deployed arthroscopically between tendon and bone, allowing surgeons to maintain their current technique while reducing bone removal through a smaller pilot hole. Placing this device at the tendon/bone interface offers a new option to treat rotator cuff tears.
BioWick’s development is supported by statistically-significant results in a Good Laboratory Practices sheep study conducted at Colorado State University.
Cayenne Medical received FDA 510(k) clearance for the BioWick SureLock Implant in early 3Q15.
The all-arthroscopic Quattro® Bolt Tenodesis Screw and Short SureLock™ mini all-suture anchor for small bone indications were among Cayenne’s products on display at last year’s AAOS meeting. While most of the company’s portfolio addresses soft tissue repair in the knee, shoulder and extremities, Cayenne also markets the Mirror™ Partial Knee, which it acquired in early 2014.
Cayenne Medical commenced U.S. launch of the BioWick™ SureLock™ Implant, an interpositional scaffold wick designed to address the biology issue associated with rotator cuff repair failure.
The BioWick scaffold wick comprises aligned, copolymer microfibers designed to mimic the extracellular matrix of a rotator cuff tendon. SureLock is deployed...
Cayenne Medical commenced U.S. launch of the BioWick™ SureLock™ Implant, an interpositional scaffold wick designed to address the biology issue associated with rotator cuff repair failure.
The BioWick scaffold wick comprises aligned, copolymer microfibers designed to mimic the extracellular matrix of a rotator cuff tendon. SureLock is deployed arthroscopically between tendon and bone, allowing surgeons to maintain their current technique while reducing bone removal through a smaller pilot hole. Placing this device at the tendon/bone interface offers a new option to treat rotator cuff tears.
BioWick’s development is supported by statistically-significant results in a Good Laboratory Practices sheep study conducted at Colorado State University.
Cayenne Medical received FDA 510(k) clearance for the BioWick SureLock Implant in early 3Q15.
The all-arthroscopic Quattro® Bolt Tenodesis Screw and Short SureLock™ mini all-suture anchor for small bone indications were among Cayenne’s products on display at last year’s AAOS meeting. While most of the company’s portfolio addresses soft tissue repair in the knee, shoulder and extremities, Cayenne also markets the Mirror™ Partial Knee, which it acquired in early 2014.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
